Professional Documents
Culture Documents
07/08/2023 1
LEARNING OBJECTIVES OF THIS MODULE
• Be able to classify diabetes based on the
pathogenesis (etiology)
• Describe the role of endocrine pancreas in glucose
homeostasis.
• Understand the autoimmune mediated pathogenesis
the of type 1 Diabetes
• Understand the role of the various factors in the
pathogeneses of type 2 Diabetes
07/08/2023 2
Diabetes Mellitus (DM)
Introduction
• Diabetes Mellitus is a metabolic disorder characterized by
persistent hyperglycemia
• Glucose level in the blood is controlled by several hormones
• Insulin secreted by beta-cells of Islet of Langerhans of
pancreas is the major hormone which controls the level of
glucose in blood
• Diabetes mellitus results either from an inadequate
secretion of insulin, an inadequate response of target cell to
insulin or combination of these factors
• Several other mechanisms including the glucagon level,
hepatic glucose production, renal glucose reabsorption and
the incretin hormones play significant role in the
pathogenesis particularly of type two diabetes
07/08/2023 3
The Pancreas and Glucose Homeostasis
07/08/2023 8
DM is classified into four general categories
Type 1 DM Type 2 DM
(1) onset of disease prior to age (1) Onset of disease after the age
30 years; of 30 years;
(2) lean body habitus; (2) are usually overweight or
(3) requirement of insulin as the obese (up to 80%, but elderly
initial therapy; individuals may be lean);
(4) propensity to develop (3) may not require insulin
ketoacidosis; and therapy initially; and
(5) an increased risk of other (4) may have associated
autoimmune disorders such as conditions such as insulin
autoimmune thyroid disease, resistance, hypertension,
adrenal insufficiency, pernicious cardiovascular disease,
anemia, celiac disease, and dyslipidemia, or PCOS.
vitiligo.
07/08/2023 12
PATHOGENESIS OF DIABETES MELLITUS
07/08/2023 13
I. Pathogenesis of Type 1 Diabetes Mellitus
• It is characterized by loss of the insulin producing
pancreatic beta-cells of islet of Langerhans
• Sensitivity and responsiveness to insulin are usually
normal
• Type 1 DM accounts for less than 10% of the general
diabetic population globally
• Type 1 DM affects children and adolescents
predominantly but can also occur in adults
• Loss of beta-cells leading to Type 1 DM is caused by
an autoimmune destruction i.e. antibodies directed
against insulin and Islet proteins
07/08/2023 14
I. Pathogenesis of Type 1 DM….
• ~ 85% of T1DM patients have circulating islet cell antibodies
Majority also have detectable anti-insulin
antibodies
• Most islet cell antibodies are directed against glutamic acid
decarboxylase (GAD) within pancreatic beta cells
• Three main factors are involved in type 1 DM pathogenesis
a) Genetic predisposition
b) Triggering environmental factor(s)
c) Development and progression of auto-Immunity
• Chronic autoimmune disorder occurring in genetically
susceptible individuals
– May be precipitated by environmental factors
07/08/2023 15
I. Pathogenesis of Type 1 DM….
• Immune system is triggered to develop an autoimmune
response against
– Altered pancreatic beta cell antigens
– Molecules in beta cells that resemble a viral protein
Is a slow T-cell mediated Auto-immune disease
Destruction of the insulin secreting cell in the
pancreatic islets takes place over many years
The pathological changes in the pre-diabetic
pancreas in Type 1 DM is characterized by
Insulitis which is the infiltration of Islet with
mono-nuclear cells containing activated
macrophages, helper cytotoxic T lymphocytes,
Natural Killer cells, B-lymphocytes
Models for Pathogenesis of T1DM
07/08/2023 19
ACE/SLK/
07/08/2023
Insulin Resistance and Type 2 DM:
Causes and Associated Conditions
Physical
Central Obesity Inactivity Aging
Lipotoxicity
Geneticss Hormones
Medications
INSULIN
RESISTANCE
Hyperglycemia
Glucotoxicity Polycystic
Ovary Syndrome
Hypertension Atherosclerosis
Dyslipidemia
07/08/2023 21
Type 2 DM is progressive and a continuum
07/08/2023 23
ACE/SLK/
06/27261/1
100
80 Start of treatment
β-cell function (%)
60
40
50% β-cell function at
diagnosis
20 p < 0.0001
0
-10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6
Time (years)
UK Prospective Diabetes Study Group. Diabetes 1995; 44: 1249–1258.
07/08/2023
ACE/SLK/
06/27261/1
Normal
insulin
secretion Insulin
resistant
Normogly-
caemia β-cell
exhaustion
increased 400
The first-phase insulin
(pmol/L)
Insulin
300
response is essentially absent
Slow and blunted second- 200
0
Progressive loss of beta-cell 0 60 120 180
functional mass Time (min)
07/08/2023 31
End of Unit-2
07/08/2023 32